Filtered By:
Vaccination: Hepatitis Vaccine
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 4921 results found since Jan 2013.
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology : WJG - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
HBV Infection Is an Intermediate-Risk Disease, Whereas Anaemia Is a Mild-to-Moderate Public Health Problem in Young Ghanaian Adults: A Four-Year Retrospective Analysis of Students' Medical Records
CONCLUSION: Intentional preventative public health campaigns regarding anaemia, HBV, and HCV infection should, respectively, target females and young adult males to increase chances of making real change in behavioural attitudes in these at-risk groups.PMID:37475793 | PMC:PMC10356218 | DOI:10.1155/2023/9318984
Source: Biomed Res - July 21, 2023 Category: Research Authors: Samuel Amoah Andrew Nicholas Yartey Praise Fosu Adjei Margaret Owusu-Akyaw Joseph Boachie David Larbi Simpong Patrick Adu Source Type: research
Past, present, and future of long-term treatment for hepatitis B virus
World J Gastroenterol. 2023 Jul 7;29(25):3964-3983. doi: 10.3748/wjg.v29.i25.3964.ABSTRACTThe estimated world prevalence of hepatitis B virus (HBV) infection is 316 million. HBV infection was identified in 1963 and nowadays is a major cause of cirrhosis and hepatocellular carcinoma (HCC) despite universal vaccination programs, and effective antiviral therapy. Long-term administration of nucleos(t)ide analogues (NA) has been the treatment of choice for chronic hepatitis B during the last decades. The NA has shown a good safety profile and high efficacy in controlling viral replication, improving histology, and decreasing th...
Source: World Journal of Gastroenterology - July 21, 2023 Category: Gastroenterology Authors: Teresa Broquetas Jos é A Carrión Source Type: research
